Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior

Experimental Brain Research

Volumn 123, Issue 1-2, 1998, Pages 60-76

  Steiner, Heinz ^a   Gerfen, Charles R ^b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Basal ganglia; Dopamine; Dynorphin; Enkephalin; Opioid; Striatum; Substantia nigra

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DYNORPHIN; ENKEPHALIN; NEUROTRANSMITTER; OPIATE PEPTIDE; RECEPTOR SUBTYPE;

BASAL GANGLION; BEHAVIOR; CONFERENCE PAPER; CORPUS STRIATUM; GENE INDUCTION; IMMEDIATE EARLY GENE; MOTOR PERFORMANCE; NERVE CELL; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DYNORPHINS; EFFERENT PATHWAYS; ENKEPHALINS; GLOBUS PALLIDUS; NEURONS; SUBSTANTIA NIGRA;

EID: 0031760312     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002210050545     Document Type: Conference Paper

References (156)

1. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375
2. Alexander GE, Crutcher MD, DeLong MR (1990) Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 85:119-146
3. Angulo JA, McEwen BS (1994) Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Brain Res Rev 19:1-28
4. 2+ influx in rat spinal cord-dorsal root ganglion cocultures. J Biol Chem 264:347-353
5. Baik J-H, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A, Le Meur M, Borrelli E (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377:424-428
6. Beckstead RM, Kersey KS (1985) Immunohistochemical demonstration of differential substance P-, Met-enkephalin-, and glutamic acid decarboxylase-containing cell and axon distributions in the corpus striatum of the cat. J Comp Neurol 232:481-498
7. Bejar JF, Harrison MB, Trugman JM (1995) Correlation of striatal dynorphin mRNA expression and behavioral sensitization following repeated D1 agonist injection. Soc Neurosci Abstr 21: 2089
8. Berretta S, Robertson HA, Graybiel AM (1992) Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J Neurophysiol 68:767-777
9. Bhat RV, Baraban JM (1993) Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J Pharmacol Exp Ther 267:496-505
10. Boegman RJ, Vincent SR (1996) Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse 22:70-77
11. Brownstein MJ, Mroz EA, Tappaz ML, Leeman SE (1977) On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra. Brain Res 135:315-323
12. Campbell A, Baldessarini RJ (1981) Tolerance to behavioral effects of haloperidol. Life Sci 29:1341-1346
13. Cenci MA, Björklund A (1993) Transection of corticostriatal afferents reduces amphetamine-and apomorphine-induced striatal Fos expression and turning behaviour in unilaterally 6-hydroxy-dopamine-lesioned rats. Eur J Neurosci 5:1062-1070
14. Cenci MA, Campbell K, Wictorin K, Björklund A (1992) Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. Eur J Neurosci 4:376-380
15. Chavkin C, James IF, Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215: 413-415
16. Cole AJ, Bhat RV, Patt C, Worley PF, Baraban JM (1992) Di, dopamine receptor activation of multiple transcription factor genes in rat striatum. J Neurochem 58:1420-1426
17. 1-9 are ligands for the kappa-subtype of opiate receptor. Nature 299:79-81
18. Curran EJ, Watson SJ (1995) Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J Comp Neurol 361:57-76
19. Daunais JB, McGinty JF (1994) Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 18:35-45
20. Delfs JM, Kong H, Mestek A, Chen Y, Yu L, Reisine T, Chesselet MF (1994) Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J Comp Neurol 345:46-68
21. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285
22. De Paoli AM, Hurley KM, Yasada K, Reisine T, Bell G (1994) Distribution of K opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study. Mol Cell Neurosci 5: 327-335
23. Dewar D, Jenner P, Marsden CD (1987) Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus. Biochem Pharmacol 36:1738-1741
24. Di Chiara G, Imperato A (1988a) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278
25. Di Chiara G, Imperato A (1988b) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080
26. Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE, Ooi GT, Grinberg A, Lee EJ, Huang SP, Bartlett PF, Jose PA, Sibley DR, Westphal H (1994) Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc Natl Acad Sci USA 91:12564-12568
27. Drago J, Gerfen CR, Westphal H, Steiner H (1996) D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience 74:813-823
28. Dragunow M, Faull R (1989) The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29:261-265
29. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience 37:287-294
30. Drake CT, Terman GW, Simmons ML, Milner TA, Kunkel DD, Schwartzkroin PA, Chavkin C (1994) Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J Neurosci 14:3736-3750
31. 2 agonists. Eur J Pharmacol 200: 171-173
32. 2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Brain Res 581:261-268
33. Ezrin-Waters C, Seeman P (1977) Tolerance of haloperidol catalepsy. Eur J Pharmacol 41:321-327
34. Fornaguera J, Carey RJ, Dai H, Huston JP, Schwarting RKW (1994a) Differentiation of motor inactivation from movement asymmetry effects in an animal model of hemi-parkinsonism. Neuroreport 6:173-176
35. Fornaguera J, Carey RJ, Huston JP, Schwarting RKW (1994b) Behavioral asymmetries and recovery in rats with different degrees of unilateral striatal dopamine depletion. Brain Res 664:178-188
36. Gauchy C, Desban M, Krebs MO, Glowinski J, Kernel ML (1991) Role of dynorphin-containing neurons in the presynaptic inhibitory control of the acetylcholine-evoked release of dopamine in the striosomes and the matrix of the cat caudate nucleus. Neuroscience 41:449-458
37. Gentleman S, Parenti M, Neff NH, Pert CB (1983) Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum. Cell Mol Neurobiol 3:17-26
38. Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133-139
39. Gerfen CR, Wilson CJ (1996) The basal ganglia. In: Swanson LW, Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy. Elsevier, Amsterdam, pp 371-468
40. Gerfen CR, Young WS III (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460:161-167
41. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432
42. Gerten CR, McGinty JF, Young WS III (1991) Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11:1016-1031
43. 2 dopamine receptor function in the striatum: coactivation of D1-and D2-dopamine receptors on separate populations of neurons results in potentiated immediate-early gene response in D1-containing neurons. J Neurosci 15:8167-8176
44. Gerten CR, Keefe KA, Steiner H (1996) D1 and D2 dopamine receptor-mediated gene regulation in the striatum. In: Merchant KM (ed) Pharmacological regulation of gene expression in the CNS. CRC, Boca Raton, pp 3-24
45. Graybiel AM, Moratalla R Robertson HA (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 87:6912-6916
46. Gross RA, Macdonald RL (1987) Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture. Proc Natl Acad Sci USA 84: 5469-5473
47. Guttenberg ND, Klop H, Minami M, Satoh M, Voorn P (1996) Colocalization of mu opioid receptor is greater with dynorphin than enkephalin in rat striatum. Neuroreport 7:2119-2124
48. Hanson GR, Merchant KM, Letter AA, Bush L, Gibb JW (1987) Methamphetamine-induced changes in the striatal-nigral dynorphin system: role of D-1 and D-2 receptors. Eur J Pharmacol 144:245-246
49. Hanson GR, Merchant KM, Letter AA, Bush L, Gibb JW (1988) Characterization of methamphetamine effects on the striatal-nigral dynorphin system. Eur J Pharmacol 155:11-18
50. Hanson GR, Singh N, Merchant K, Johnson M, Gibb JW (1995) The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse. Drug Alcohol Depend 37:107-110
51. Heidbreder CA, Goldberg SR, Shippenberg TS (1993) The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res 616:335-338
52. Heidbreder CA, Babovic-Vuksanovic D, Shoaib M, Shippenberg TS (1995) Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists. J Pharmacol Exp Ther 275:150-163
53. Hersch SM, Ciliax BJ, Gutekunst CA, Rees HD, Heilman CJ, Yung KK, Bolam JP, Ince E, Yi H, Levey AI (1995) Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15:5222-5237
54. Hess EJ, Norman AB, Creese I (1988) Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologie effects on D1 and D2 dopamine receptors. J Nwurosei 8:2361-2370
55. Hong JS, Yang H-YT, Fratta W, Costa E (1978) Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic drugs. J Pharmacol Exp Ther 205:141-147
56. Hope B, Kosofsky B, Hyman SE, Nestler EJ (1992) Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci USA 89: 5764-5768
57. Hope BT, Nye HE, Kelz MB, Self DW, Iadarola MJ, Nakabeppu Y, Duman RS, Nestler EJ (1994) Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13: 1235-1244
58. Hurd YL, Herkenham M (1992) Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res Mol Brain Res 16:97-104
59. Hurd YL, Herkenham M (1993) Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13:357-369
60. Hurd YL, Weiss F, Koob GF, And NE, Ungerstedt U (1989) Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. Brain Res 498:199-203
61. Hurd YL, Brown EE, Finlay JM, Fibiger HC, Gerfen CR (1992) Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res Mol Brain Res 13:165-170
62. Hyman SE, Nestler EJ (1996) Initiation and adaptation: a paradigm for understanding psychotropie drug action. Am J Psychiatry 153:151-162
63. Hyman SE, Cole RL, Schwarzschild M, Cole D, Hope B, Konradi C (1996) Molecular mechanisms of striatal gene regulation: a critical role for glutamate in dopamine-mediated gene induction. In: Merchant KM (ed) Pharmacological regulation of gene expression in the CNS. CRC, Boca Raton, pp 115-131
64. Johanson C-E, Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3-52
65. Johansson B, Lindström K, Fredholm BB (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59:837-849
66. Kalivas PW, Duffy P (1993) Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266-275
67. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16:223-244
68. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45:599-606
69. Karler R, Calder LD, Thai LH, Bedingfield JB (1994) A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res 658:8-14
70. Kawaguchi Y, Wilson CJ, Emson PC (1990) Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci 10:3421-3438
71. Keefe KA, Gerfen CR (1995) D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66:903-913
72. Kita H, Kitai ST (1988) Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res 447:346-352
73. Konradi C, Kobierski LA, Nguyen TV, Heckers S, Hyman SE (1993) The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc Natl Acad Sci USA 90:7005-7009
74. Konradi C, Leveque J-C, Hyman SE (1996) Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 16:4231-4239
75. Koob GF (1996) Drug addiction: the yin and yang of hedonic homeostasis. Neuron 16:893-896
76. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723
77. Kosofsky BE, Genova LM, Hyman SE (1995) Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striatum. J Comp Neurol 351:41-50
78. Kuczenski R, Segal DS (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J Pharmacol Exp Ther 262:1085-1094
79. Kuhar MJ, Pilotte NS (1996) Neurochemical changes in cocaine withdrawal. Trends Pharmacol Sci 17:260-264
80. LaHoste GJ, Yu J, Marshall JF (1993) Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 90:7451-7455
81. Le Moine C, Bloch B (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355:418-426
82. Le Moine C, Normand E, Guitteny AF, Fouque B, Teoule R, Bloch B (1990) Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proe Natl Acad Sci USA 87:230-234
83. Le Moine C, Normand E, Bloch B (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci USA 88:4205-4209
84. Le Moine C, Kieffer B, Gaveriaux-Ruff C, Befort K, Bloch B (1994) Delta-opioid receptor gene expression in the mouse forebrain: localization in cholinergic neurons of the striatum. Neuroscience 62:635-640
85. Li SJ, Sivan SP, McGinty JF, Jiang HK, Douglass J, Calavetta L, Hong JS (1988) Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J Pharmacol Exp Ther 246: 403-408
86. Li SJ, Jiang HK, Stachowiak MS, Hudson PM, Owyang V, Nanry K, Tilson HA, Hong JS (1990) Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. Brain Res Mol Brain Res 8:219-225
87. Longoni R, Spina L, Mulas A. Carboni E, Garau L, Melchiorri P, Di Chiara G (1991) (D-Ala2) deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J Neurosci 11:1565-1576
88. Maneuf YP, Mitchell IJ, Crossman AR, Brotchie JM (1994) On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp Neurol 125:65-71
89. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7:2445-2464
90. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ (1994a) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350:412-438
91. Mansour A, Fox CA, Meng F, Akil H, Watson SJ (1994b) K, receptor mRNA distribution in the rat CNS: comparison to K receptor binding and prodynorphin mRNA. Mol Cell Neurosci 5: 124-144
92. Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22-29
93. Masuda Y, Murai S, Itoh T (1982) Tolerance and reverse tolerance to haloperidol catalepsy induced by the difference of administration interval in mice. Jpn J Pharmacol 32:1186-1188
94. Melzer P, Steiner H (1997) Stimulus-dependent expression of immediate-early genes in rat somatosensory cortex. J Comp Neurol 380:145-153
95. Meng F, Xie G-X, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H (1993) Cloning and pharmacological characterization of a rat K opioid receptor. Proc Natl Acad Sci USA 90:9954-9958
96. Minami M, Hosoi Y, Toya T, Katao Y, Maekawa K, Katsumata S, Yabuuchi K, Onogi T, Satoh M (1993) In situ hybridization study of kappa-opioid receptor mRNA in the rat brain. Neurosci Lett 162:161-164
97. Moratalla R, Robertson HA, Graybiel AM (1992) Dynamic regulation of NGFI-A (zif 268, egrI) gene expression in the striatum. J Neurosci 12:2609-2622
98. Moratalla R, Xu M, Tonegawa S, Graybiel AM (1996) Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci USA 93:14928-14933
99. Morgan JI, Curran T (1989) Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci 12:459-462
100. Mulder AH, Wardeh G, Hogenboom F, Frankhuyzen AL (1984) Kappa-and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308:278-280
101. Nisenbaum LK, Kitai ST, Crowley WR, Gerfen CR (1994) Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion. Neuroscience 60:927-937
102. Nisenbaum LK, Crowley WR, Kitai ST (1996) Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression. Brain Res Mol Brain Res 37:209-216
103. Park MR, Lighthall JW, Kitai ST (1980) Recurrent inhibition in the rat neostriatum. Brain Res 194:359-369
104. Paterson SJ, Robson LE, Kosterlitz HW (1983) Classification of opioid receptors. Br Med Bull 39:31-36
105. Paul ML, Graybiel AM, David J-C, Robertson HA (1992) D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J Neurosci 12:3729-3742
106. Reid M, Herrera-Marschitz M, Hökfelt T, Terenius L, Ungerstedt U (1988) Differential modulation of striatal dopamine release by intranigral injection of γ-aminobutyric acid (GABA), dynorphin A and substance P. Eur J Pharmacol 147:411-420
107. Reiner A, Anderson KD (1990) The patterns of neurotransmitter and neuropeptide cooccurrence among striatal projection neurons: conclusions based on recent findings. Brain Res Brain Res Rev 15:251-265
108. Robertson GS, Fibiger HC (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46:315-328
109. Robertson GS, Vincent SR, Fibiger HC (1990) Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res 523:288-290
110. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49:285-296
111. Robertson HA (1992) Immediate-early genes, neuronal plasticity, and memory. Biochem Cell Biol 70:729-737
112. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291
113. Rosen JB, Chuang E, Iadarola MJ (1994) Differential induction of Fos protein and a Fos-related antigen following acute and repeated cocaine administration. Brain Res Mol Brain Res 25: 168-172
114. Ruskin DN, Marshall JF (1994) Amphetamine-and cocaine-induced fox in the rat striatum depends on D2 dopamine receptor activation. Synapse 18:233-240
115. Sagar SM, Sharp FR, Curran T (1988) Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240: 1328-1331
116. Schoffelmeer ANM, Rice KC, Jacobson AE, Van Gelderen JG, Hogenboom F, Heijna MH, Mulder AH (1988) Mu-, delta-and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Eur J Pharmacol 154:169-178
117. Schwarting RKW, Huston JP (1996a) Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 49:215-266
118. Schwarting RKW, Huston JP (1996b) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50:275-331
119. Segal DS, Kuczenski R (1992a) In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res 571:330-337
120. Segal DS, Kuczenski R (1992b) Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res 577:351-355
121. Sheng M, Greenberg ME (1990) The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4:477-485
122. Simmons ML, Terman GW, Gibbs SM, Chavkin C (1995) L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells. Neuron 14:1265-1272
123. Sivam SP (1989) Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J Pharmacol Exp Ther 250:818-824
124. Smiley PL, Johnson M, Bush L, Gibb JW, Hanson GR (1990) Effects of cocaine on extrapyramidal and limbic dynorphin systems. J Pharmacol Exp Ther 253:938-943
125. Spanagel R, Herz A, Shippenberg TS (1992) Opposing topically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050
126. Spangler R, Unterwald EM, Kreek MJ (1993) 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res Mol Brain Res 19:323-327
127. Steiner H, Gerfen CR (1992) Time course of alterations in substance P, dynorphin, enkephalin and c-fos gene expression in striatal neurons during chronic cocaine treatment. Soc Neurosci Abstr 18:1044
128. Steiner H, Gerfen CR (1993) Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 13:5066-5081
129. Steiner H, Gerfen CR (1995) Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J Comp Neurol 353:200-212
130. Steiner H, Gerfen CR (1996) Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: relative contributions of pre-and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction. J Comp Neurol 376:530-541
131. Steiner H, Gerfen CR (1999) Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons. Neuroscience (in press)
132. Steiner H, Mariotti R, Gerfen CR (1995) Enkephalin inhibits immediate-early gene expression induced by blockade of D2 dopamine receptors in striatum. Soc Neurosci Abstr 21:1904
133. Svingos AL, Moriwaki A, Wang JB, Uhl GR, Pickel VM (1996) Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin. J Neurosci 16:4162-4173
134. Svingos AL, Clarke CL, Pickel VM (1998) Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin. J Neurosci 18:1923-1933
135. Tang F, Costa E, Schwartz JP (1983) Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci USA 80:3841-3844
136. Thompson LA, Walker JM (1990) Inhibitory effects of the kappa opiate U50,488 in the substantia nigra pars reticulata. Brain Res 517:81-87
137. Torres G, Rivier C (1993) Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Res Bull 30:173-176
138. Trujillo KA, Day R, Akil H (1990) Regulation of striatonigral prodynorphin peptides by dopaminergic agents. Brain Res 518:244-256
139. Van Bockstaele FJ, Gracy KN, Pickel VM (1995) Dynorphin-immunoreactive neurons in the rat nucleus accumbens: ultrastructure and synaptic input from terminals containing substance P and/ or dynorphin. J Comp Neurol 351:117-133
140. Vargo JM, Marshall JF (1995) Time-dependent changes in dopamine agonist-induced striatal Fos immunoreactivity are related to sensory neglect and its recovery after unilateral prefrontal cortex injury. Synapse 20:305-315
141. Vaurgo JM, Marshall JF (1997) Reduced eticlopride-induced fos expression in caudate-putamen and globus pallidus after unilateral frontal cortex injury: relation to neglect. Neuroscience 76:1083-1095
142. Vincent SR, Hökfelt T, Christensson I, Terenius L (1982) Immunohistochemical evidence for a dynorphin immunoreactive striatonigral pathway. Eur J Pharmacol 85:251-252
143. Voorn P, Roest G, Groenewegen HJ (1987) Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions. Brain Res 412:391-396
144. Wang JQ, McGinty JF (1996) Glutamatergic and cholinergic regulation of immediate-early gene and neuropeptide gene expression in the striatum. In: Merchant KM (ed) Pharmacological regulation of gene expression in the CNS. CRC, Boca Raton, pp 81-113
145. Wang JQ, Daunais JB, McGinty JF (1994) NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18:343-353
146. Wang H, Moriwaki A, Wang JB, Uhl GR, Pickel VM (1996) Ultrastructural immunocytochemical localization of mu opioid receptors and Leu-5-enkephalin in the patch compartment of the rat caudate-putamen nucleus. J Comp Neurol 375:659-674
147. Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM (1988) Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J Pharmacol Exp Ther 246:282-286
148. Wilson CJ, Groves PM (1980) Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular injection of horseradish peroxidase. J Comp Neurol 194:599-615
149. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
150. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S (1994) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742
151. 2 receptor agonists. Neuroscience 63:427-434
152. Young ST, Porrino LJ, Iadarola MJ (1991) Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci USA 88:1291-1295
153. Young WS III, Bonner TI, Brann MR (1986) Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 83:9827-9831
154. Yung KK, Bolarn JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65:709-730
155. Yung KK, Smith AD, Levey AI, Bolam JP (1996) Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: evidence from dopamine receptor and neuropeptide immunostaining. Eur J Neurosci 8:861-869
156. Ziólkowska B, Höllt V (1993) The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum. Neurosci Lett 156:39-42